Literature DB >> 25728360

Regional variations in percutaneous absorption of methimazole: an in vitro study on cat skin.

K E Hill1, J P Chambers1, B R Jones1, C F Bolwell1, D Aberdein1, P C Mills2.   

Abstract

The use of transdermal gel medications in cats has become popular in veterinary medicine due to the ease of administration compared to oral medication. The research to support systemic absorption of drugs after transdermal gel administration and the preferred skin region to apply these drugs in cats is limited. The aim of this study was to characterize the effect of different skin regions on the percutaneous absorption pharmacokinetics of a commercially available transdermal methimazole after a finite dose was applied to feline skin in vitro. A commercial formulation of methimazole (10 mg) was applied to four skin regions (the inner stratum corneum of the ear, groin, neck, and thorax regions) from six cats. The receptor medium was sampled up to 36 h postapplication, and methimazole concentrations were measured using high-performance liquid chromatography. Methimazole was absorbed more completely across the pinnal skin, compared to the groin, neck, and thorax (P < 0.001), which justifies application to the pinna to maximize efficacy and also to minimize the effects of grooming.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25728360     DOI: 10.1111/jvp.12220

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  3 in total

1.  Drug exposure and clinical effect of transdermal mirtazapine in healthy young cats: a pilot study.

Authors:  Kellyi K Benson; Lara B Zajic; Paula K Morgan; Sarah R Brown; Ryan J Hansen; Paul J Lunghofer; Luke A Wittenburg; Daniel L Gustafson; Jessica M Quimby
Journal:  J Feline Med Surg       Date:  2016-09-01       Impact factor: 2.015

2.  A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss.

Authors:  Melinda Poole; Jessica M Quimby; Tianhua Hu; Daizie Labelle; William Buhles
Journal:  J Vet Pharmacol Ther       Date:  2018-12-02       Impact factor: 1.786

3.  Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.

Authors:  Jessica M Quimby; Kellyi K Benson; Stacie C Summers; Ashlie Saffire; Andrea K Herndon; Shasha Bai; Daniel L Gustafson
Journal:  J Feline Med Surg       Date:  2019-06-04       Impact factor: 2.015

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.